title: Impact of the measurement of troponin on the triage, prognosis, and treatment of patients with chest pain.
abstract: There are several issues driving the rapid advancement in diagnostic technology for acute cardiac syndromes. First is safety, primarily the need to improve sensitivity in lower-risk patients presenting with symptoms suggestive of ischemia; second is fiscal, especially to reduce the cost for the evaluation of low-risk chest pain patients; and third is therapeutic, including the ability to effectively risk-stratify patients who may be candidates for more aggressive therapy.
authors.affiliation: Acute Cardiac Care, Virginia Commonwealth University, Medical College of Virginia and the McGuire Veterans Administration Hospital, Richmond 23284, USA. rjesse@hsc.vcu.edu
authors.forename: R L
authors.initials: RL
authors.lastname: Jesse
mesh_terms: D015415:Biomarkers / Q000097:blood; D002637:Chest Pain / Q000175:diagnosis* / Q000628:therapy; D003327:Coronary Disease / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy; D003402:Creatine Kinase / Q000097:blood; D004636:Emergency Service, Hospital; D006801:Humans; D007527:Isoenzymes; D009336:Necrosis; D011379:Prognosis; D014218:Triage / Q000379:methods*; D019210:Troponin I / Q000097:blood*; D020107:Troponin T / Q000097:blood*
chemical_list: D015415:Biomarkers; D007527:Isoenzymes; D019210:Troponin I; D020107:Troponin T; D003402:Creatine Kinase